Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors
- 1 March 2019
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 166, 480-501
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21572281, 21877132)
- Scientific Plan of Guangzhou City (201704030087)
- Scientific Plan of Guangdong Province (2017A020211003)
- Introduction of Innovative R&D Team Program of Guangdong (2009010058)
- National Special Research Program of China for Important Infectious Diseases (2018ZX10302103, 2017ZX10202102)
- Important key program of natural science foundation of China (81730060)
- International Collaboration Program of Natural Science Foundation of China and US NIH (81561128007)
- Joint-Innovation Program in Healthcare for Special Scientific Research Projects of Guangzhou (201803040002)
- National Natural Science Foundation of China (31500740)
- Natural Science Foundation of Guangdong (2015A030310442)
- Science and Technology Planning Project of Guangzhou (201704020226)
- Pearl River S&T Nova Program of Guangzhou (201806010118)
This publication has 30 references indexed in Scilit:
- Sulfamoylbenzamide Derivatives Inhibit the Assembly of Hepatitis B Virus NucleocapsidsJournal of Virology, 2013
- In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutationsAntiviral Therapy, 2012
- Virus assembly, allostery and antiviralsTrends in Microbiology, 2011
- Sulfonylureido thiazoles as fructose-1,6-bisphosphatase inhibitors for the treatment of Type-2 diabetesBioorganic & Medicinal Chemistry Letters, 2010
- In vitro screening for molecules that affect virus capsid assembly (and other protein association reactions)Nature Protocols, 2007
- BAY 41-4109 has multiple effects on Hepatitis B virus capsid assemblyJournal of Molecular Recognition, 2006
- An in vitro fluorescence screen to identify antivirals that disrupt hepatitis B virus capsid assemblyNature Biotechnology, 2006
- Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of NucleocapsidsScience, 2003
- Phenylpropenamide Derivatives AT-61 and AT-130 Inhibit Replication of Wild-Type and Lamivudine-Resistant Strains of Hepatitis B Virus In VitroAntimicrobial Agents and Chemotherapy, 2002
- A Small Molecule Inhibits and Misdirects Assembly of Hepatitis B Virus CapsidsJournal of Virology, 2002